Exomes in the Clinic

Two teams report molecular diagnosis rates of 25 percent sequencing separate sets of patients with undiagnosed, suspected genetic conditions.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, FOTOHUNTERSequencing the coding portions of people’s genomes could improve medicine’s ability to identify genetic disorders, according to two independent papers published in JAMA this week (October 18).

“[The studies] provide compelling evidence for the ability of exome sequencing to establish a molecular diagnosis,” the University of North Carolina, Chapel Hill’s Jonathan Berg wrote in an editorial accompanying the works.

In one paper, researchers from the University of California, Los Angeles, David Geffen School of Medicine showed that in a sample of 814 patients with suspected but undiagnosed genetic conditions who had their exomes sequenced recently, the overall molecular diagnosis rate was 26 percent. The diagnosis rate was higher for patients whose family members were also sequenced.

Separately, a team led by investigators at the Baylor College of Medicine in Houston, Texas, reported in a larger sample—2,000 patients whose exomes were also sequenced in the last few years—a molecular diagnosis rate of 25 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery